iMedix

What iMedix does

iMedix is a consumer-facing health information platform founded in 2006 and operated as a free-to-user website (imedix.com). The company publishes editorial health news, blog content, drug reference entries, disease information pages, and a doctor directory, and operates a community Q&A section where registered users and physicians can exchange health-related information. The underlying technical foundation is the iMedix Medical Content Engine (versioned at 3.13.37), a proprietary CMS that powers the drug database, condition pages, and community features; the platform also distinguishes FDA-approved medications from international analogs with regulatory status indicators. Multi-language support is provided via an English-language site and a German-language variant (imedix.com/de). The company is headquartered at 511 Avenue of the Americas, New York, with firmographic data referencing a Tel Aviv presence and employs 1-10 people.

iMedix generates revenue through two streams: display advertising across the platform and affiliate referral fees from outbound links to third-party online pharmacy services. All core features — drug lookup, health news, Q&A participation, doctor profiles, and blog content — are available free of charge with no subscription, membership, or transaction fees. Distribution is entirely product-led and self-serve: users sign up directly on the website, and acquisition relies on organic search, content marketing, and an organic social presence across Facebook, Instagram, LinkedIn, X, YouTube, and Pinterest, with no evidence of a paid sales or marketing team. The company has raised $2,000,000 in a single undisclosed-investor funding round in December 2007 and has not announced subsequent capital raises, partnerships, acquisitions, or material management changes.

Name

iMedix

Legal name

iMedix

Website

https://imedix.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

iMedix is a free, ad- and affiliate-supported consumer health information platform offering drug databases, health news, doctor profiles, and community Q&A in English and German to general health-seeking consumers worldwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Tel Aviv

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Advertising: iMedix displays advertisements, affiliate links, and sponsored materials throughout the platform. Some pages contain affiliate links directing users to third-party online pharmacy services.
2. Affiliate Revenue: The platform earns commissions through affiliate links to external pharmacy websites and potentially other third-party products/services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels10 records

Core offering

iMedix operates a free, consumer-facing health information website that delivers a curated drug database (distinguishing FDA-approved medications from international analogs), a doctor directory, disease reference content, health news articles, an editorial blog, and a community Q&A platform where users can ask health questions and receive responses from other users and registered physicians. The service is available in English and German and is funded through advertising and affiliate commissions rather than user fees.

Product overview

iMedix is a consumer health information platform offering a unified suite of health-related content and community features. The core offering is the iMedix Medical Content Engine (version 3.13.37), which powers the main website delivering medical news articles, drug database references, disease information, and doctor directories. The platform integrates a community Q&A component where users can ask health questions and receive peer or expert responses. The drug database distinguishes between FDA-approved medications and international analogs. The product portfolio includes the main health information website, specialized content sections (News, Blog, Drugs, Diseases, Doctors), and community engagement tools, all accessible in English and German language variants.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Database Reference database of medications covering FDA-approved drugs (e.g., Rybelsus, Diflucan, Amoxil, Vibramycin, Acyclovir, Zithromax, Proscar, Levitra) and international or analog medications, with regulatory approval status indicators (green checkmarks for FDA-approved; warning indicators for non-approved). Targeted at consumers researching medications.
• Doctor Directory Searchable directory of doctors with profile pages, specialties, and contact information enabling users to find healthcare providers such as urologists and other specialists.
• Health News Section Editorial news articles covering diabetes management, cardiovascular health, FDA approvals, drug updates, and medical research developments, published on an ongoing cadence.
• Community Q&A Platform User-generated question-and-answer community where members can post health-related questions and receive responses from other community members and registered medical professionals.
• Health Blog Editorial blog providing in-depth health articles and medical explainers on topics including medications, treatments, and health conditions.
• Disease Information Database Reference content covering various diseases and health conditions accessible to platform users for educational purposes.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Healthline: Healthline is a major consumer-facing health information publisher providing medically-reviewed articles, condition guides, and drug information. It competes with iMedix in the same SEO-driven health content category with significantly greater editorial resources and brand recognition.
• Verywell Health: Verywell Health is a Dotdash Meredith consumer health content property offering medically-reviewed articles on conditions, medications, and wellness. It targets the same audience as iMedix with similar health information and lifestyle content formats.
• Everyday Health: Everyday Health is a consumer health and wellness media platform offering condition content, drug information, and lifestyle health articles. It targets the same patient and health-information-seeking audience as iMedix with overlapping content categories.
• MedlinePlus: MedlinePlus is the National Library of Medicine's consumer health information platform providing drug information, disease references, and health topics. It competes with iMedix's disease information database and drug reference content with the credibility advantage of government backing.
• Drugs.com: Drugs.com is a leading consumer drug information database providing FDA approval data, side effects, interactions, and user reviews. It directly parallels iMedix's drug database sub-product and serves the same consumer medication research use case.
• Medical News Today: Medical News Today is a health news and information publisher covering medical research, drug approvals, and health conditions. It competes with iMedix's health news section and SEO-driven editorial content for the same consumer health information audience.
• RxList: RxList is a drug information database owned by WebMD providing detailed prescription medication data, pill identifiers, and consumer drug content. It directly overlaps with iMedix's drug database product and consumer medication reference use case.
• WebMD: WebMD is the dominant consumer health information platform offering drug databases, condition information, physician directories, and health news. It directly competes with iMedix's core offering of medication references, disease content, and editorial health articles targeting health-conscious consumers.

Broad incumbents

• Mayo Clinic: Mayo Clinic's patient information website is a leading authoritative health reference providing disease information, drug references, and care guidance. As a broad incumbent with deep clinical credibility, it competes with iMedix for SEO traffic on health information queries.
• Sharecare: Sharecare is a digital health company offering consumer health content alongside virtual care, wellness programs, and health assessments. While broader in scope, its consumer health information and Q&A features overlap with iMedix's content platform model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/iMedix
• YouTubeyoutube.com/@iMedixon
• Facebookfacebook.com/imedixon
• LinkedInlinkedin.com/company/imedix
• Instagraminstagram.com/imedixcom
• Pinterestpinterest.com/iMedixcom

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iMedix